<?xml version="1.0" encoding="UTF-8"?>
<ref id="b32-1031825">
 <label>32.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hochhaus</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Saglio</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Hughes</surname>
    <given-names>TP</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial</article-title>. 
  <source>Leukemia</source>. 
  <year>2016</year>;
  <volume>30</volume>(
  <issue>5</issue>):
  <fpage>1044</fpage>â€“
  <lpage>1054</lpage>.
  <pub-id pub-id-type="pmid">26837842</pub-id>
 </mixed-citation>
</ref>
